financetom
Business
financetom
/
Business
/
CrowdStrike Stock Is Falling Today: What's Driving Shares Lower?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CrowdStrike Stock Is Falling Today: What's Driving Shares Lower?
Jun 4, 2025 7:13 AM

CrowdStrike Holdings Inc ( CRWD ) shares are trading lower Wednesday on the heels of the company’s mixed first-quarter financial results. Multiple analysts weighed in following the print. Here’s what you need to know.

What Happened: CrowdStrike ( CRWD ) reported first-quarter revenue of $1.10 billion, missing analyst estimates of $1.11 billion, and first-quarter adjusted earnings of 73 cents per share, beating analyst estimates of 66 cents per share.

Total revenue climbed 20% year-over-year and annual recurring revenue increased 22%. The company generated free cash flow of $279.4 million and ended the period with $4.61 billion in cash and short-term investments.

"We started the fiscal year with record Q1 large deal and MSSP momentum alongside sustained 97% gross retention and consistently strong net retention as the market consolidates on Falcon as its cybersecurity platform of choice for the agentic AI era," said George Kurtz, co-founder, president and CEO of CrowdStrike ( CRWD ).

CrowdStrike’s second-quarter guidance appears to be weighing on shares. The company guided for second-quarter revenue between $1.145 billion and $1.152 billion versus estimates of $1.23 billion. CrowdStrike ( CRWD ) also forecasted adjusted earnings of 82 cents to 84 cents per share versus estimates of 92 cents per share, according to Benzinga Pro.

It’s also worth noting that CrowdStrike ( CRWD ) stock hit new all-time highs ahead of the print, which likely led to elevated expectations for the cybersecurity company. Analysts appear to be largely optimistic following the company’s quarterly results.

Canaccord Genuity downgraded CrowdStrike ( CRWD ) from Buy to Hold, but raised the price target from $420 to $475. Meanwhile, analysts at Needham and Rosenblatt maintained Buy ratings and price targets ranging from $515 to $530. Stephens & Co. analyst Todd Weller maintained an Overweight rating and raised the price target from $450 to $540.

CrowdStrike ( CRWD ) also announced Wednesday morning that it surpassed $1 billion in sales under its partnership with GuidePoint Security.

CRWD Price Action: CrowdStrike ( CRWD ) shares were down 6.98% at $454.65 at the time of publication Wednesday, according to Benzinga Pro.

Read Next:

US Private Sector Hiring Slows The Most In 2 Years: ‘Powell Must Now Lower The Rate,’ Trump Says

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ubisoft shareholders in talks over possible buyout terms, sources say
Ubisoft shareholders in talks over possible buyout terms, sources say
Dec 6, 2024
* Guillemot family seen wanting to retain control in buyout * Tencent ( TCTZF ) undecided on increasing stake * Minority shareholders push for sale amid stock decline By Amy-Jo Crowley and Julie Zhu LONDON/HONG KONG, Dec 6 (Reuters) - Shareholders of Ubisoft Entertainment SA are considering how to structure a possible buyout of the Assassin's Creed video game maker...
After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer
After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer
Dec 6, 2024
On Friday, the FDA accepted and granted Priority Review AstraZeneca Plc's ( AZN ) supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) for patients with muscle-invasive bladder cancer (MIBC). The Prescription Drug User Fee Act date, the FDA action date for their regulatory decision, is anticipated during the second quarter of 2025. The supplement application is based on data from the NIAGARA...
Mattr Prices $129.3 Million Offering of Debt Subscription Receipts
Mattr Prices $129.3 Million Offering of Debt Subscription Receipts
Dec 6, 2024
09:05 AM EST, 12/06/2024 (MT Newswires) -- Mattr ( MTTRF ) on Friday priced an offering of 125,000 debt subscription receipts at $1,034 each, including accrued but unpaid interest, for $129.3 million in proceeds. The company plans to use the proceeds to pay a portion of the purchase price for its previously announced indirect acquisition of AmerCable, which is expected...
Sector Update: Consumer Stocks Advance Pre-Bell Friday
Sector Update: Consumer Stocks Advance Pre-Bell Friday
Dec 6, 2024
09:05 AM EST, 12/06/2024 (MT Newswires) -- Consumer stocks were advancing pre-bell Friday as the Consumer Staples Select Sector SPDR Fund ( XLP ) was up 0.1% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) was 0.8% higher recently. Lululemon athletica (LULU) shares were over 8% higher after the company reported a surge in fiscal Q3 earnings...
Copyright 2023-2026 - www.financetom.com All Rights Reserved